“…It was suggested that NK cell-mediated cytotoxicity might be downregulated by G-CSF through the PI3K/Akt and ERK/MAPK signaling molecules, and the PI3K/Akt signaling then decreased expression of cytotoxicity-related molecules, TPI, while the ERK/MAPK signaling may be involved in regulation of other genes, such as cellular adhesion, polarity, development, cytokine production and granule secretion. 27,28 Recently, clinicians have begun to use new agents such as plerixafor (AMD3100) to optimize the mobilization of HSC before transplantation for treatment of hematologic diseases and inborn errors of metabolism. 23,36 Our results may provide additional important information regarding regulation of NK cell activity for developers of potential drugs for advanced stem cell mobilization in HSCT.…”